Navigation Links
Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
Date:3/19/2008

Acquires Rights from UCSD to Develop Cysteamine for the Treatment of NASH Enters Convivia(TM) Formulation and Manufacturing Agreement with Patheon

Pharmaceuticals

NOVATO, Calif., March 19 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. ("Bennu"), has acquired an exclusive worldwide license to intellectual property from the University of California, San Diego ("UCSD") around the use of Cysteamine, and Delayed Release Cysteamine ("DR Cysteamine") for the treatment of Non-alcoholic Steatohepatitis ("NASH"). In collaboration with doctors from UCSD School of Medicine, Bennu plans to initiate a Phase 2a clinical study of DR Cysteamine in NASH patients in 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

NASH is a form of progressive liver disease resulting from triglyceride fat accumulation in vacuoles of the liver cells, which causes decreased liver function and potentially leads to cirrhosis and liver failure. Cysteamine is currently approved by the FDA for the management of nephropathic cystinosis ("cystinosis"), a genetic lysosomal storage disease characterized by the poor transport of cystine out of lysosomes.

Ted Daley, President of Bennu stated, "We are delighted to extend our relationship with UCSD. Additional rights to Cysteamine in NASH complement our license to DR Cysteamine for cystinosis and neurodegenerative diseases. In addition to our ongoing clinical trial in cystinosis, we look forward to initiating a clinical trial of DR Cysteamine in NASH patients in 2008."

In a separate announcement, Raptor said that Bennu has entered into a formulation and manufacturing agreement for its Convivia(TM) product candidate with Patheon Pharmaceuticals
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Raptor Pharmaceuticals Acquires Orphan Clinical Program
2. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
3. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
4. Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
5. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
7. NPS Pharmaceuticals Reports 2007 Financial Results
8. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
9. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
10. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
11. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ring industry-leading event September 10 - 11, ...URN HILLS, Mich., Sept. 5 /- Plexus S...software for the medical manufacturing,enterprise,...gy Conference,September 10-11, 2008 at the San Jos..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...
(Date:9/5/2008)...ember 5 /- The 33rd ESMO Congress,in ...gy, serves as a,meeting place for medical oncologi...th colleagues from other disciplines., The Congre...interaction, a teaching ground, and a place to dis... cancer research in Europe, the training of young,...
(Date:9/5/2008)...- BioSpecifics,Technologies...ical company,developing first in class collagenase...d an agreement to significantly improve the deal t... Peyronie,s disease by buying down its,future roya...oSpecifics has modified its previously announced a...
(Date:9/4/2008)... 4 /- MedQuist Inc.,(Nasdaq...ors has elected John,F. Jastrem, Colin J. O,Brien,...tember 4, 2008. Prior to the election of the new d... of the board from seven to 10 members., Accordin...a, "We are,pleased to have this opportunity to fur...
Breaking Biology Technology:Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2MedQuist Announces Additions to Board of Directors 2MedQuist Announces Additions to Board of Directors 3
...Scanner 3000 , New Advances in Scanner Desi...mic Range , , , The Af...oundation for continued evolution of the GeneChip ...m, supporting continued feature size reduction for... of microarray-based products. The Affymetrix Gene...
...s Damaskinos a , Arthur E. Dixon a and Lucy E. J...., A12-550 Parkside Dr., Waterloo, Ontario N2L 5V4,...d Laurier University, 75 University Ave. W., Water... ABSTRACT , Conventional widefield light...been indispensable for pathology and drug discover...
...d Mass Spectrometry Application Report , K...Deca XP Plus Equine serum Acepromazine , ...n Jose, CA USA , Wayne Skinner and S... Introduction , Acepromazine is w... tranquilizer to better facilitate handling of the...
...d Mass Spectrometry Application Note , Key...antum Discovery Enhanced Mass- Resolution , ...ry Tucker 1 , and Walter Korfmacher 1 , ...inetics, Schering-Plough Research Institute, Kenil...omerset, NJ, USA , Overview , ...
Other Biology Technology:The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 2The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 3The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 4The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 5The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 6The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 7The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 8The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 9The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 2A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 3A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 4A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 5A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 6A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 7A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 8A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 9A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 11A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 12A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 13A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 14A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 15A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 16A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 17A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 18A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 19A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 20A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 21A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 22A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 23A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 24A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 25A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 26A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 27
(Date:9/5/2008)...ulations of wild animals face the challenge of sur...ial College London and Universit Claude Bernard Ly...sland off the west coast of Scotland responds to t...ailability and the unpredictability of winter stor...vealed, "When times are good and food is plentiful...
(Date:9/5/2008)...cksburg, Va. -- Innovative work on a new type of h...ssistant professor of mechanical engineering at Vi... Early Career Development (CAREER) award of $400,0... development of specific models and experiments to...with a stent that has a unique type of in situ pol...
(Date:9/5/2008)...ess release is available in French and Spanish ...ment of Nutrition and Bromatology and Department...da have carried out a study in which they have re...e university population who follows Ramadan. , A...time macronutrient consumption levels are not appr...
(Date:9/4/2008)...g, 5 September 2008 Even scientists define ,a gen...se that the media also have various ways of framin...appearing in the October 2008 issue of EMBO repor...e analysis of 300 articles in British and Norwegia...Mail from the UK; and Aftenposten, Dagbladet, and ...
Breaking Biology News(10 mins):Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3Nutritionists of the UGR suggest diet improvements during Ramadan 2What is a gene? 2More Than 78 000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 20722 1More Than 78 000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 20722 2PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 1PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 2PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 3PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 4MDwise Enrollment Exceeds 300 000 Members 20718 1MDwise Enrollment Exceeds 300 000 Members 20718 2EPA Approves XDS CALUX 28R 29 as Alternate Dioxin Test Method 4435 2245 1EPA Approves XDS CALUX 28R 29 as Alternate Dioxin Test Method 4435 2245 2
...ive project with implications,for malaria vaccine ...mics and gene expression studies to trace how mala...move between their hosts and insect,vectors.,That ...ing researchers,understand when different genes sw...ugh seven different life stages. In turn, that,mol...
...nal team of scientists has used gene therapy in tw...e normal movements in monkeys and rats with a drug...rch, detailed online in the scientific publication...ly describes one strategy to halt Parkinson,s dise... devastating side effects that occur when treating...
...Library of Medicine, a part of the National Instit...election from the papers of one of the twentieth c...s Profiles in Science Web site. , ,Don,t miss Cri...test collection on Profiles in Science represents ... of Medicine and the Wellcome Library for the Hist...
...rted last week reveal how an,evolutionary innovati...species has given rise to a deep-seated dependency...ulations.,The new work illustrates how genetic exc...n give rise to a system of interdependence at a,hi..., the production of,worker ants for both species. ...
Other Biology News:Scientists reveal molecular secrets of the malaria parasite 2Scientists reveal molecular secrets of the malaria parasite 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 2Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 3Ants Genetic Engineering Leads To Species Interdependency 2
BD FACSAria Cell Sorting System from BD Biosciences - Immunocytometry Systems
...tial for hunting and analyzing the rare transcript...quencing projects, microarrays, functional screeni...ed for normalization of cDNA enriched with full-le...g. While most normalization methods are not well s...
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)
Biology Products: